Illustration: Shutterstock
Stock market melts down over Trump’s tariffs, and biotech's pain keeps growing
As President Donald Trump’s tariffs roil financial markets, biopharma is no exception.
The XBI, an index fund viewed as the biotech’s market barometer, was down …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
